<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Orthop J Sports Med</journal-id><journal-id journal-id-type="iso-abbrev">Orthop J Sports Med</journal-id><journal-id journal-id-type="publisher-id">OJS</journal-id><journal-id journal-id-type="hwp">spojs</journal-id><journal-title-group><journal-title>Orthopaedic Journal of Sports Medicine</journal-title></journal-title-group><issn pub-type="epub">2325-9671</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage CA: Los Angeles, CA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4901782</article-id><article-id pub-id-type="doi">10.1177/2325967116S00009</article-id><article-id pub-id-type="publisher-id">10.1177_2325967116S00009</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Intravenous versus Intra-articular Tranexamic Acid in Patients Undergoing Primary Unilateral Total Knee Arthroplasty</article-title><subtitle>A Prospective Randomized Double Blinded Non-inferiority Trial</subtitle></title-group><contrib-group><contrib contrib-type="author"><name><surname>Macdessi</surname><given-names>Samuel</given-names></name><xref ref-type="aff" rid="aff1-2325967116S00009">1</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Darren</given-names></name><xref ref-type="aff" rid="aff1-2325967116S00009">1</xref></contrib><contrib contrib-type="author"><name><surname>Goyal</surname><given-names>Navendu</given-names></name><xref ref-type="aff" rid="aff1-2325967116S00009">1</xref></contrib><contrib contrib-type="author"><name><surname>Harris</surname><given-names>Ian</given-names></name><xref ref-type="aff" rid="aff1-2325967116S00009">1</xref></contrib><contrib contrib-type="author"><name><surname>Kirsh</surname><given-names>George</given-names></name><xref ref-type="aff" rid="aff1-2325967116S00009">1</xref></contrib><contrib contrib-type="author"><name><surname>Rowden</surname><given-names>Neville</given-names></name><xref ref-type="aff" rid="aff1-2325967116S00009">1</xref></contrib></contrib-group><aff id="aff1-2325967116S00009"><label>1</label>Sydney Knee Specialists, St George Private Hospital, Sydney, Australia</aff><pub-date pub-type="epub"><day>16</day><month>2</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2016</year></pub-date><volume>4</volume><issue>2 Suppl</issue><issue-title>2015 Australian Knee Society Annual Meeting Abstracts</issue-title><elocation-id>2325967116S00009</elocation-id><permissions><copyright-statement>&#x000a9; The Author(s) 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This open-access article is published and distributed under the Creative Commons Attribution - NonCommercial - No Derivatives License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link>), which permits the noncommercial use, distribution, and reproduction of the article in any medium, provided the original author and source are credited. You may not alter, transform, or build upon this article without the permission of the Author(s). For reprints and permission queries, please visit SAGE&#x02019;s Web site at <ext-link ext-link-type="uri" xlink:href="http://www.sagepub.com/journalsPermissions.nav">http://www.sagepub.com/journalsPermissions.nav</ext-link>.</license-p></license></permissions><abstract><sec><title>Objectives:</title><p>Tranexamic acid (TXA) is commonly used in primary total knee arthroplasty (TKA) to reduce blood loss, however the most appropriate route of administration is still debated. This study was conducted to compare the two most commonly used routes of TXA administration, intravenous (IV) and intra-articular (IA).</p></sec><sec><title>Methods:</title><p>This study was conducted as a non-inferiority, double blinded randomized trial to compare IA TXA with IV TXA in terms of efficacy in reducing blood loss as measured by post-operative Hb drop and transfusion rates. We hypothesized that IA TXA is not inferior to IV TXA in reducing blood loss and transfusion requirements.</p></sec><sec><title>Results:</title><p>One hundred and sixty eight patients were analysed. Mean day 1 and day 2 post-operative Hb values for both the groups were statistically similar (p=0.88, p=0.95 respectively). Also, no statistical difference was seen on comparison of change in Hb between pre-operative and day 1 or day 2 values (p=0.55, p=0.58 respectively). There were no transfusions given in either group.</p></sec><sec><title>Conclusion:</title><p>Intra-articular TXA is non-inferior to IV TXA in terms of fall in Hb and blood transfusion requirements. This trial further establishes and supports the use of IA TXA for primary TKA.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>edited-state</meta-name><meta-value>corrected-proof</meta-value></custom-meta></custom-meta-group></article-meta></front></article>